HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

seglitide

more potent than somatostatin for inhibition of insulin, glucagon & growth hormone release; used experimentally in treatment of Alzheimer's disease; somatostatin receptor antagonist
Also Known As:
L 363586; L-363586; MK 678; MK-678; cyclo(MATTLVP); cyclo(N-Me-Ala-Tyr-Trp-Lys-Val-Phe); cyclo(N-methylalanyl-tyrosyl-tryptophyl-lysyl-valyl-phenylalanyl); seglitide acetate; seglitide monoacetate; Cyclic(N-methyl-L-alanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-phenylalanyl)
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Seizures (Seizure)
2. Neoplasms (Cancer)
3. Cholera

Related Drugs and Biologics

1. Somatostatin Receptors (Somatostatin Receptor)
2. Somatostatin (Somatotropin Release-Inhibiting Factor)
3. Somatostatin-28
4. Octreotide (Sandostatin)
5. Messenger RNA (mRNA)
6. Peptides
7. Neuraminidase (Sialidase)
8. Kainic Acid (Kainate)
9. Forskolin
10. harpin (messenger)

Related Therapies and Procedures

1. Subcutaneous Injections